5 / 10
Page 16
Volume 02
Clinical Pharmacology and Toxicology Research
Toxicology 2019
November 11-12, 2019
November 11-12, 2019 | London, UK
TOXICOLOGY AND CLINICAL TOXICOLOGY
2
nd
International Conference on
Clin Pharmacol Toxicol Res, Volume 02
Utility of lipid sink in treatment of Refractory acquired Methemoglobinemia: A case
report
Anuj Khatri
Sri Ganga Ram Hospital, India
M
ethemoglobinemia can be congenital or acquired. Acquired methemoglobinemia occurs as a result of ingestion of
some substances such as toluene, nitrates. Patient presents with cyanosis which is not explainable by the respiratory or
cardiac cause. Most frequently used drug in treatment is methylene blue. We report a case of a patient with severe acquired
methemoglobinemia in 14 months old baby, due to ingestion of toluene. He was cyanosed which was refractory to oxygen
therapy and without any cardiac and respiratory disease. He had persistent high levels of methemoglobin, despite giving multiple
doses of methylene blue and exchange transfusion. Finally, methemoglobin levels were controlled by automated RBC exchange
transfusion and intralipid infusion.
Biography
Anuj Khatri is working as a PICU Consultant in a tertiary care hospital in New Delhi. He is involved in the management of critically ill
children admitted in Pediatric Intensive Care Unit, Cardiac Intensive Care Unit and transplant ICU. While working in PICU, he has been
a part of the team who have managed different poisonings amongst children.
e
:
dranujkhatri@gmail.com